Intima Bioscience Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Intima Bioscience General Information

Description

Developer of gene and cell therapy designed for curative intent in solid tumor cancer. The company's platform specializes in clinical-stage gene and cellular therapies, to assess the safety and efficacy of genetically-engineered, neoantigen-specific tumor-infiltrating lymphocytes, enabling researchers to inhibit gastrointestinal cellular cells from expanding.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 3 Columbus Circle
  • New York, NY 10019
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3 Columbus Circle
  • New York, NY 10019
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Intima Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Feb-2023 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Dec-2015 Completed Generating Revenue
1. Early Stage VC 01-Jul-2015 $1.2M $1.2M Completed Generating Revenue
To view Intima Bioscience’s complete valuation and funding history, request access »

Intima Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Intima Bioscience’s complete cap table history, request access »

Intima Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of gene and cell therapy designed for curative intent in solid tumor cancer. The company's platform specialize
Drug Discovery
New York, NY

Emeryville, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Intima Bioscience Competitors (1)

One of Intima Bioscience’s competitors is Eureka Therapeutics, a Venture Capital-Backed company based in Emeryville, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eureka Therapeutics Venture Capital-Backed Emeryville, CA
You’re viewing 1 of 1 competitors. Get the full list »

Intima Bioscience Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Morningside Group Venture Capital Minority
To view Intima Bioscience’s complete investors history, request access »

Intima Bioscience FAQs

  • When was Intima Bioscience founded?

    Intima Bioscience was founded in 2014.

  • Where is Intima Bioscience headquartered?

    Intima Bioscience is headquartered in New York, NY.

  • What industry is Intima Bioscience in?

    Intima Bioscience’s primary industry is Drug Discovery.

  • Is Intima Bioscience a private or public company?

    Intima Bioscience is a Private company.

  • What is Intima Bioscience’s current revenue?

    The current revenue for Intima Bioscience is .

  • How much funding has Intima Bioscience raised over time?

    Intima Bioscience has raised $21.7M.

  • Who are Intima Bioscience’s investors?

    Morningside Group has invested in Intima Bioscience.

  • Who are Intima Bioscience’s competitors?

    Eureka Therapeutics is a competitor of Intima Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process